Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

Overview of attention for article published in Frontiers in immunology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,463 followers.

https://t.co/8ZT1AF9GPs

Reply Repost Favourite

RT @FrontImmunol: New Research: Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors…

Reply Repost Favourite

New Research: Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer: Background In the era of immunotherapy, the optimal combination… https://t.co/E

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.